Insulin sensitizers for the treatment of non-alcoholic fatty liver disease

doi:10.4254/wjh.v6.i4.199

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 6, Issue 4

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7198)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-2) series.

Item

Count

PDF

448

WORD

291

HTML

4406

Figures (1-1)

130

Tables (1-2)

143

Sum=5418

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

997

Download

783

Sum=1780

Apr 27, 2014 (publication date) through Apr 26, 2024

Times Cited of This Article

Times Cited (54)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Hepatol. Apr 27, 2014; 6(4): 199-206
Published online Apr 27, 2014. doi: 10.4254/wjh.v6.i4.199

Open in New Tab Full Size Figure Download Figure

Figure 1 The relationship between obesity, insulin resistance and hepatic steatosis. VLDL: Very low-density lipoprotein; TG:

Citation: Ozturk ZA, Kadayifci A. Insulin sensitizers for the treatment of non-alcoholic fatty liver disease. World J Hepatol 2014; 6(4): 199-206
URL: https://www.wjgnet.com/1948-5182/full/v6/i4/199.htm
DOI: https://dx.doi.org/10.4254/wjh.v6.i4.199